| Issuer | % of Class | Filed |
|---|---|---|
|
Pyxis Oncology, Inc.
13D/A
Amendment 5
PYXS · 747324101
|
11.2% |
4/2/2025
Event 3/31/2025
|
|
Pyxis Oncology, Inc.
13D/A
Amendment 4
PYXS · 747324101
|
10.3% |
12/23/2024
Event 12/23/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.